Tamara Pagler
Overview
Explore the profile of Tamara Pagler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
1129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murphy A, Akhtari M, Tolani S, Pagler T, Bijl N, Kuo C, et al.
J Clin Invest
. 2011 Oct;
121(10):4138-49.
PMID: 21968112
Leukocytosis is associated with increased cardiovascular disease risk in humans and develops in hypercholesterolemic atherosclerotic animal models. Leukocytosis is associated with the proliferation of hematopoietic stem and multipotential progenitor cells...
2.
Yvan-Charvet L, Pagler T, Gautier E, Avagyan S, Siry R, Han S, et al.
Science
. 2010 May;
328(5986):1689-93.
PMID: 20488992
Elevated leukocyte cell numbers (leukocytosis), and monocytes in particular, promote atherosclerosis; however, how they become increased is poorly understood. Mice deficient in the adenosine triphosphate-binding cassette (ABC) transporters ABCA1 and...
3.
Yvan-Charvet L, Kling J, Pagler T, Li H, Hubbard B, Fisher T, et al.
Arterioscler Thromb Vasc Biol
. 2010 May;
30(7):1430-8.
PMID: 20448206
Objective: To examine the effects of treatments with niacin or anacetrapib (an inhibitor of cholesteryl ester transfer protein) on the ability of high-density lipoprotein (HDL) to promote net cholesterol efflux...
4.
Terasaka N, Yu S, Yvan-Charvet L, Wang N, Mzhavia N, Langlois R, et al.
J Clin Invest
. 2008 Oct;
118(11):3701-13.
PMID: 18924609
Plasma HDL levels are inversely related to the incidence of atherosclerotic disease. Some of the atheroprotective effects of HDL are likely mediated via preservation of EC function. Whether the beneficial...
5.
Tall A, Yvan-Charvet L, Terasaka N, Pagler T, Wang N
Cell Metab
. 2008 May;
7(5):365-75.
PMID: 18460328
High-density lipoprotein (HDL) has been identified as a potential target in the treatment of atherosclerotic vascular disease. The failure of torcetrapib, an inhibitor of cholesteryl ester transfer protein (CETP) that...